#CMS

CMS has indefinitely delayed a Medicare pilot focused on obesity medication coverage after insurance plans signaled they were not ready to participate.

A new CMS proposal would repeal a pathway that lets breakthrough medical devices receive supplementary payments, potentially tightening reimbursement for a closely watched class of products.

The Centers for Medicare and Medicaid Services' innovation arm is more than doubling its staff to develop pilot programs that reduce drug costs across Medicare and Medicaid, signaling aggressive federal action on pharmaceutical pricing.